Jäntti, Henna
Jonk, Steffi
Gómez Budia, Mireia
Ohtonen, Sohvi
Fagerlund, Ilkka
Fazaludeen, Mohammad Feroze
Aakko-Saksa, Päivi
Pebay, Alice
Lehtonen, Šárka
Koistinaho, Jari
Kanninen, Katja M.
Jalava, Pasi I.
Malm, Tarja
Korhonen, Paula
Article History
Received: 20 April 2023
Accepted: 25 January 2024
First Online: 15 February 2024
Declarations
:
: Human iPSC cultures and experiments were performed compliant with the Declaration of Helsinki of the WMA, 1964 and with the permission from the Research Ethics Committee of the Northern Savo Hospital District (license no. 123/2016). The donors of fibroblasts signed a written informed consent prior to sample collection. MBE2968 and TOB064 lines were generated upon approval from the human research ethics committees of the Royal Victorian Eye and Ear Hospital (11/1031H), University of Melbourne (1545394), University of Tasmania (H0014124), with the requirements of the National Health & Medical Research Council of Australia and conformed with the Declarations of Helsinki [CitationRef removed, CitationRef removed]. MAD6 line was generated upon approval from the committee on Research Ethics of Northern Savo Hospital district (license no. 123/2016) [CitationRef removed]. BIONi010-C2 line was purchased from the European Bank for Induced Pluripotent Stem Cells (EBiSC), with the permission for research use as detailed in the cell line information pack (CLIP), available at ExternalRef removed (accessed on the 1 December 2021).
: Not applicable.
: The authors declare that they have no competing interests.